An observational study in Sport Injury, sponsored by Universidad Católica de Ávila. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-04-16.
Sponsored by Universidad Católica de Ávila · Observational
Observational study on Nimbus shoes for daily training with 8mm drop and designed for heavier than normal weight. Shoe weight is 300g with highly structured buttress and upper with internal heat-sealed midfoot for greater lateral stability. This is a Novablast shoe with a mixed profile for training and competition with 8mm drp and higher midfoot compression range with less lateral containment.
258 studies on the registry are indexed under Athletic Injuries; 45 are open to participants now.
This study's planned enrollment of 20 is below the median of 100 across 91 observational studies indexed under Athletic Injuries.
Browse Athletic Injuries studies →Universidad Católica de Ávila is the lead sponsor of 26 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
regular runners with functional standing equine
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Other: 250 mg Nimbus shoe
lightweight shoe
functional equine
footprints measurement with camera and digital goniometer (measured in degrees).
Time frame: 5 weeks
algometry
pressure pain threshold measured with digital algometer (measured in Newtons).
Time frame: 5 weeks
Plan to share: Undecided
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad Católica de Ávila